scispace - formally typeset
W

Wenhao Qin

Researcher at Second Military Medical University

Publications -  15
Citations -  401

Wenhao Qin is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Hepatocellular carcinoma & Cancer. The author has an hindex of 8, co-authored 14 publications receiving 233 citations.

Papers
More filters
Journal ArticleDOI

PSMD10/gankyrin induces autophagy to promote tumor progression through cytoplasmic interaction with ATG7 and nuclear transactivation of ATG7 expression.

TL;DR: It is reported that PSMD10/gankyrin promotes autophagy in hepatocellular carcinoma (HCC) in response to starvation or stress through 2 complementary routes, and this results present a novel mechanism involving modulation of ATG7 by PS MD10 in sustainingAutophagy, promoting HCC cell survival against starvation or chemotherapy.
Journal ArticleDOI

Cholesterol inhibits hepatocellular carcinoma invasion and metastasis by promoting CD44 localization in lipid rafts.

TL;DR: It is reported that high levels of cholesterol predict good survival and low disease recurrence after surgery and pharmacologically promoting CD44 retention inside lipid rafts obviously attenuated HCC migration and invasion, providing a potential therapeutic strategy to prolong the survival of HCC patients.
Journal ArticleDOI

ACADL plays a tumor-suppressor role by targeting Hippo/YAP signaling in hepatocellular carcinoma.

TL;DR: It is found that ACADL was frequently downregulated in hepatocellular carcinoma (HCC), and its low expression was significantly correlated with poor clinical prognosis of HCC patients and targeting ACadL/Yap may be a potential strategy for HCC precise treatment.
Journal ArticleDOI

Inflammation-Dependent IL18 Signaling Restricts Hepatocellular Carcinoma Growth by Enhancing the Accumulation and Activity of Tumor-Infiltrating Lymphocytes

TL;DR: It is found that IL18 exerted inflammation-dependent tumor-suppressive effects largely by promoting the differentiation, activity, and survival of tumor-infiltrating T cells and differences in the expression of IL18 in tumor tissue versus nontumors were more predictive of patient outcome than overall tissue expression.